Pharmacodynamic Profiles of Different Calcium Channel Blockers
- 1 April 1986
- journal article
- review article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 58 (S2), 31-42
- https://doi.org/10.1111/j.1600-0773.1986.tb02519.x
Abstract
The cardiovascular effects of different calcium channel blockers (CCB), exemplified by nifedipine, verapamil and diltiazem, are not identical. Some of these differences in effect may be due to the different CCBs interacting with different calcium channel subtypes in the tissues, and/or that the drug-receptor sites are separate. The drugs also have different abilities to activate the sympathetic nervous system, nifedipine increasing and diltiazem decreasing the baroreflex sensitivity. Verapamil, but not nifedipine and diltiazem, has a postjunctional alpha-adrenoceptor blocking effect, and can also increase the release of noradrenaline from adrenergic nerves by blocking pre-junctional alpha-adrenoceptors. In addition, verapamil may have a reserpine-like action on sympathetic nerves. The vasodilator actions of CCBs are not uniform, but seem to vary between species, different vascular regions, and different agents. Mechanisms other than blockade of influx of calcium from the extracellular medium have been suggested to explain these differences, including inhibition of intracellular calcium release, blockade of postjunctional alpha-adrenoceptors, interaction with calmodulin, inhibition of cyclic AMP phosphodiesterase, stimulation of Na+-, K+-activated ATPase, stimulation of a calcium pump, and a direct interaction with the contractile proteins. The heterogeneity in pharmacodynamic profile characterizing the CCBs is conspicuous, and may be of importance when selecting agents for the treatment of various cardiovascular and non-cardiovascular disorders.Keywords
This publication has 61 references indexed in Scilit:
- Effects of nifedipine on baroreflex modulation of vascular resistance in manAmerican Heart Journal, 1985
- Vascular Selectivity of FelodipineDrugs, 1985
- “Calcium antagonists” and “calcium agonists”: Is there a place in pharmacology for these two misnomers?Life Sciences, 1984
- The dependence of the cardiac effects of nifedipine on the responses of the peripheral vascular system.Circulation, 1984
- Are dihydropyridine binding sites voltage sensitive calcium channels?Life Sciences, 1984
- Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs.Circulation, 1984
- Calcium antagonists: A new class of drugsPharmacology & Therapeutics, 1983
- The effect of nifedipine on arterial pressure and reflex cardiac control.Circulation, 1983
- Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.Circulation, 1981
- Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.Circulation, 1980